Goal Setting to Promote Physical Activity Adherence in Midlife Adults
2 other identifiers
interventional
144
1 country
1
Brief Summary
Engaging in regular physical activity during midlife is a key lifestyle behavior associated with reduced risk for Alzheimer's disease and related dementias (AD/ADRD). Yet nearly half of midlife adults (48%) do not meet national physical activity guidelines. The purpose of this mechanistic trial is to identify effective goal setting techniques to enhance psychosocial processes of self-regulation for the successful promotion of PA and adherence to national PA guidelines among midlife adults, with the long-term goal of reducing AD/ADRD risk
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 17, 2023
CompletedStudy Start
First participant enrolled
July 17, 2023
CompletedFirst Posted
Study publicly available on registry
August 7, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
July 17, 2025
July 1, 2025
3.5 years
July 17, 2023
July 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in accelerometer-measured moderate-to-vigorous intensity physical activity from baseline to 6- and 9-months
Participants will wear wrist-worn ActiGraph GT9X Link Activity monitors the activity monitor on their non-dominant wrist during all waking hours for 7 consecutive days to provide an assessment of usual activity.
Assessed at baseline, 6-months, 9-months
Change in Fitbit-assessed moderate-to-vigorous intensity physical activity
Participants will wear a wrist-worn Fitbit activity monitor daily throughout the 9-month intervention.
Assessed daily up to 9-months
Change in self-reported moderate-to-vigorous intensity physical activity from baseline to 6- and 9-months
Self-reported minutes per week of moderate-to-vigorous physical activity assessed by the 7-day Physical Activity Recall.
Assessed at baseline, 6-months, 9-months
Secondary Outcomes (5)
Change in physical activity self-regulation from baseline to 6- and 9-months
Assessed monthly up to 9-months
Change in physical activity behavioral strategies from baseline to 6- and 9-months
Assessed monthly up to 9-months
Change in physical activity self-efficacy from baseline to 6- and 9-months
Assessed monthly up to 9-months
Change in general self-regulation from baseline to 6- and 9-months
Assessed monthly up to 9-months
Change in General Self-Efficacy from baseline to 6- and 9-months
Assessed monthly up to 9-months
Other Outcomes (18)
Change in immediate verbal memory from baseline to 6- and 9-months
Assessed at baseline, 6-months, 9-months
Change in delayed verbal memory from baseline to 6- and 9-months
Assessed at baseline, 6-months, 9-months
Change in visual memory from baseline to 6- and 9-months
Assessed at baseline, 6-months, 9-months
- +15 more other outcomes
Study Arms (4)
Static weekly physical activity goal of 150 minutes/week
EXPERIMENTALParticipants will receive a physical activity action planning intervention and assigned a static weekly physical activity goal of 150 minutes/week of moderate-intensity activity; action planning sessions will focus on the participant achieving this weekly goal.
Incremental weekly physical activity goal increase
EXPERIMENTALParticipants will receive a physical activity action planning intervention and assigned a weekly physical activity goal that is 20% greater than the level of moderate-intensity physical activity performed the previous week; action planning sessions will focus on the participant achieving their assigned goal.
Self-selected weekly physical activity goal
EXPERIMENTALParticipants will receive a physical activity action planning intervention and will self-select their own moderate-intensity physical activity goal each week; action planning sessions will focus on helping participants achieve their self-selected goal.
No stated weekly physical activity goal (comparison group)
EXPERIMENTALParticipants will receive a physical activity action planning intervention that does not include explicitly stated physical activity goals to achieve.
Interventions
Theory-driven behavioral physical activity promotion intervention.
Eligibility Criteria
You may qualify if:
- Aged 45 to 65 years
- BMI between 30 kg/m2 to 50 kg/m2
- Participants must weigh a minimum of 110 pounds
- Engaging in 60 minutes or less of self-reported moderate-to-vigorous physical activity at screening (based on Exercise Vital Sign Questionnaire)
- Self-reported ownership of a smartphone with an iOS or Android operating system (necessary for participants to track their activity using a Fitbit activity monitor)
You may not qualify if:
- Endorsing an item on the Physical Activity Readiness Questionnaire (PAR-Q), unless a physician's note is provided
- Resting blood pressure greater than 200/110 mmHG as assessed at the baseline study assessment (unless a physician's note is provided)
- Pregnant or planning to become pregnant in next 8-months (Phase 1) or 12 months (Phase 2)
- Plans to relocate out of metropolitan Phoenix, Arizona area in the next 8-months (Phase 1) or 12 months (Phase 2)
- Participation in another physical activity, nutrition or weight loss program at time of screening or at any time during the intervention
- Being previously prescribed one of the 5 approved Alzheimer's medications, including: Donepezil (Aricept), Rivastigmine (Exelon), Galantamine (Razadyne), Memantine (Namenda), Memantine + Donepezil (Namzaric)
- Score of 16 or higher on the Center for Epidemiological Studies-Depression Scale (CES-D)
- Self-reported current diagnosis of major depression
- Currently taking 2 or more ant-depression drugs
- History of stroke
- Incarcerated individuals (i.e., Prisoners)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Arizona State Universitylead
- National Institute on Aging (NIA)collaborator
Study Sites (1)
Arizona State University
Phoenix, Arizona, 85004, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 17, 2023
First Posted
August 7, 2023
Study Start
July 17, 2023
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
July 17, 2025
Record last verified: 2025-07